semaglutide and cardiovascular outcomes in obesity without diabetes journal club 2.4 mg delivered a statistically significant 20% risk reduction major adverse events – REGENHEALTHSOLUTIONS (RHS) Oral Semaglutide and Cardiovascular Outcomes

You will want to make sure your provider is aware of any other medications you are taking before starting Wegovy (semaglutide) drug product or compounded semaglutide

Whichever route you choose, remember that lifestyle factors like nutrition, exercise, and stress management also play a crucial role in metabolic health.

Stomach In 2023, Novo Nordisk was sued by a woman with Type 2 diabetes who alleged Ozempic was among medications that caused gastroparesis, or stomach paralysis

Vitamin B12 deficiency can lead to neurological symptoms such as numbness, tingling, and weakness in the extremities, as well as cognitive impairment and mood disturbances

Metal-based catalytic drug development for next-generation cancer therapy

Understanding Your Individual Response With Genetic Testing The PlexusDx Precision Peptide Genetic Test ($298) analyzes FTO and MC4R variants that relate to GLP-1 and related signaling pathways